Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation

Surgical creation of arteriovenous fistulas has been the gold standard for vascular access in hemodialysis patients. However, recent advancements in endovascular technology, the need for alternative hemodialysis access options in nonsurgical candidates, and patient preference for nonsurgical approac...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmed Kamel Abdel Aal, Juri Bassuner, Husameddin El Khudari, Reema F. Alrasheed, Shahroz Aziz, Mohamed Shahin, Ammar Almehmi, Bridget Kowalczyk
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2025-01-01
Series:The Arab Journal of Interventional Radiology
Subjects:
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791222
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583138116632576
author Ahmed Kamel Abdel Aal
Juri Bassuner
Husameddin El Khudari
Reema F. Alrasheed
Shahroz Aziz
Mohamed Shahin
Ammar Almehmi
Bridget Kowalczyk
author_facet Ahmed Kamel Abdel Aal
Juri Bassuner
Husameddin El Khudari
Reema F. Alrasheed
Shahroz Aziz
Mohamed Shahin
Ammar Almehmi
Bridget Kowalczyk
author_sort Ahmed Kamel Abdel Aal
collection DOAJ
description Surgical creation of arteriovenous fistulas has been the gold standard for vascular access in hemodialysis patients. However, recent advancements in endovascular technology, the need for alternative hemodialysis access options in nonsurgical candidates, and patient preference for nonsurgical approaches have led to the development of percutaneous arteriovenous fistula creation. Currently, there are two Food and Drug Administration (FDA) approved systems, namely WavelinQ and Ellipsys. The aim of this article is to review the available literature on the outcomes of percutaneous arteriovenous fistula creation. Studies have reported high technical success rates for both the WavelinQ and Ellipsys systems. However, re-interventions were necessary for maturation, maintenance of patency, and treatment of complications. Reported re-intervention rates have varied across studies, device used, and patient populations, ranging from 0.46 to 2.7 per patient-year. While percutaneous arteriovenous fistula creation shows promise in terms of technical success rates, patency, and patient satisfaction, the rate of re-interventions adds to the overall procedural burden and may impact cost-effectiveness.
format Article
id doaj-art-125d7a8b317f45ed994f1cc54a0562c0
institution Kabale University
issn 2542-7075
2542-7083
language English
publishDate 2025-01-01
publisher Thieme Medical and Scientific Publishers Pvt. Ltd.
record_format Article
series The Arab Journal of Interventional Radiology
spelling doaj-art-125d7a8b317f45ed994f1cc54a0562c02025-01-29T00:28:22ZengThieme Medical and Scientific Publishers Pvt. Ltd.The Arab Journal of Interventional Radiology2542-70752542-70832025-01-01090100100510.1055/s-0044-1791222Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula CreationAhmed Kamel Abdel Aal0Juri Bassuner1Husameddin El Khudari2Reema F. Alrasheed3Shahroz Aziz4Mohamed Shahin5Ammar Almehmi6Bridget Kowalczyk7Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Radiology, University of Alabama at Birmingham, Birmingham, Alabama, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesDepartment of Internal Medicine and Radiology, University of Alabama at Birmingham, Birmingham, Alabama, United StatesDepartment of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston, Texas, United StatesSurgical creation of arteriovenous fistulas has been the gold standard for vascular access in hemodialysis patients. However, recent advancements in endovascular technology, the need for alternative hemodialysis access options in nonsurgical candidates, and patient preference for nonsurgical approaches have led to the development of percutaneous arteriovenous fistula creation. Currently, there are two Food and Drug Administration (FDA) approved systems, namely WavelinQ and Ellipsys. The aim of this article is to review the available literature on the outcomes of percutaneous arteriovenous fistula creation. Studies have reported high technical success rates for both the WavelinQ and Ellipsys systems. However, re-interventions were necessary for maturation, maintenance of patency, and treatment of complications. Reported re-intervention rates have varied across studies, device used, and patient populations, ranging from 0.46 to 2.7 per patient-year. While percutaneous arteriovenous fistula creation shows promise in terms of technical success rates, patency, and patient satisfaction, the rate of re-interventions adds to the overall procedural burden and may impact cost-effectiveness.http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791222arteriovenous fistulahemodialysisWavelinQEllipsysre-interventionspatencymaturation
spellingShingle Ahmed Kamel Abdel Aal
Juri Bassuner
Husameddin El Khudari
Reema F. Alrasheed
Shahroz Aziz
Mohamed Shahin
Ammar Almehmi
Bridget Kowalczyk
Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
The Arab Journal of Interventional Radiology
arteriovenous fistula
hemodialysis
WavelinQ
Ellipsys
re-interventions
patency
maturation
title Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
title_full Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
title_fullStr Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
title_full_unstemmed Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
title_short Early and Midterm Outcomes of Percutaneous Arteriovenous Fistula Creation
title_sort early and midterm outcomes of percutaneous arteriovenous fistula creation
topic arteriovenous fistula
hemodialysis
WavelinQ
Ellipsys
re-interventions
patency
maturation
url http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1791222
work_keys_str_mv AT ahmedkamelabdelaal earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation
AT juribassuner earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation
AT husameddinelkhudari earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation
AT reemafalrasheed earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation
AT shahrozaziz earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation
AT mohamedshahin earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation
AT ammaralmehmi earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation
AT bridgetkowalczyk earlyandmidtermoutcomesofpercutaneousarteriovenousfistulacreation